BGLC BioNexus Gene Lab Corp

Nasdaq bionexusgenelab.com


$ 4.63 $ 0.01 (0.22 %)    

Friday, 14-Nov-2025 15:48:29 EST
QQQ $ 608.97 $ 0.46 (0.08 %)
DIA $ 472.00 $ -2.94 (-0.62 %)
SPY $ 672.14 $ -0.11 (-0.02 %)
TLT $ 88.93 $ -0.51 (-0.57 %)
GLD $ 375.93 $ -6.91 (-1.8 %)
$ 4.53
$ 4.36
$ 4.48 x 100
$ 4.68 x 100
$ 4.54 - $ 4.70
$ 2.01 - $ 15.60
14,571
na
8.14M
$ 1.01
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-18-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 04-15-2025 12-31-2024 10-K
4 11-15-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 04-16-2024 12-31-2023 10-K
8 11-20-2023 09-30-2023 10-Q
9 08-16-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-31-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 04-06-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-18-2021 03-31-2021 10-Q
19 03-30-2021 12-31-2020 10-K
20 11-09-2020 09-30-2020 10-Q
21 11-03-2020 09-30-2020 10-Q
22 08-11-2020 06-30-2020 10-Q
23 05-08-2020 03-31-2020 10-Q
24 03-31-2020 12-31-2019 10-K
25 11-14-2019 09-30-2019 10-Q
26 08-09-2019 06-30-2019 10-Q
27 05-15-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 bionexus-enters-into-definitive-agreements-with-fidelion-and-tongshu-to-commercialize-vitaguard-tumor-nave-liquid-biopsy-platform-for-minimal-residual-disease

BioNexus Gene Lab Corp. ("BGLC, ("BGLC," NASDAQ:BGLC) today announced it has entered into definitive agreements wit...

 bionexus-gene-lab-files-100m-shelf-registration-and-establishes-20m-atm-program-to-support-growth-in-precision-oncology-and-gene-based-technologies

BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("BioNexus" or the "Company"), a biotechnology company advancing precisio...

 bionexus-gene-lab-files-for-mixed-shelf-of-up-to-100m

-SEC Filing

 bionexus-gene-enters-partnership-with-birchbiomed-to-lead-birchs-10m-funding-round-through-equity-investment-collaboration

BioNexus Gene Lab Corp (NASDAQ:BGLC, "BGLC", or the "Company")), today announced that it has entered into a non...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION